| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.33 | 0.006 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |